An official government website affiliated with the Government of the Kingdom of Saudi Arabia.

Mon 12 Oct 2026

Beta version

Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

Registered with the Digital Government Authority under number:

20250831619

Suggestions

Semaglutide

Request Type	New Registration
Drug Type	Generic (Multisource) Drug
Trade Name	Glucentra
Scientific Name	Semaglutide
Strength	1.34 mg/ml
Dosage Form	Solution for injection in pre-filled pen
Approval Date	2026-02-01
SFDA Approved Use	Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise • As monotherapy when metformin is considered inappropriate due to intolerance or contraindications • In addition to other medicinal products for the treatment of diabetes. Glucentra is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease.